NCT05539391

Brief Summary

This study has to objective to assess, in adults' patients needing tracheal intubation because of vital distress, the effect of a combined strategy to reduce intubation-related morbidity. This strategy will associate systematic use of rocuronium as paralyzing agent to facilitate tracheal intubation, bag face-mask ventilation before intubation and Gum Elastic Bougie (GEB) use.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

22 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jan 2023Sep 2026

First Submitted

Initial submission to the registry

August 4, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 14, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

January 14, 2023

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

September 24, 2025

Status Verified

September 1, 2025

Enrollment Period

3.6 years

First QC Date

August 4, 2022

Last Update Submit

September 23, 2025

Conditions

Keywords

Out-of-hospitalIntubationComplicationsVital distressRapid sequence intubationRocuroniumGum Elastic Bougie

Outcome Measures

Primary Outcomes (1)

  • Severe intubation-related complications occurring during the first hour after intubation

    Proportion of patients with severe intubation-related complications occurring during the first hour after intubation The severe intubation-related complications are: * Cardiac arrest. * At least one arterial hypotension episode defined by systolic blood pressure\<90 mmHg. * At least one hypoxemia episode defined by an occurrence of a new episode of oxygen. * Saturation \< 90%. * Severe cardiac arrhythmia: ventricular tachycardia. * Pulmonary aspiration, reported by the physician. * Esophageal intubation. * Unintentional extubation. Severe intubation-related complications will be recorded by the emergency physician in charge of the patient.

    Day 0

Secondary Outcomes (10)

  • Difficulty of the intubation process - Intubation Difficulty

    Day 0

  • Difficulty of the intubation process - Intubation conditions assessed by the Copenhagen

    Day 0

  • Difficulty of the intubation process - Alternative techniques.

    Day 0

  • Difficulty of the intubation process - Intubation attempts

    Day 0

  • Difficulty of the intubation process - Intubation failures under direct laryngoscopy.

    Day 0

  • +5 more secondary outcomes

Study Arms (2)

Treatment group

EXPERIMENTAL

Combination rapid sequence intubation (RSI) with use of rocuronium and the bag-mask ventilation between induction and Gum Elastic Bougie GEB will be systematically used at the first attempt to facilitate intubation.

Other: Data patientOther: Physical examinationProcedure: Rapid sequence intubation (RSI) : Rocuronium /Bag-mask ventilation /GEB

Control Group

ACTIVE COMPARATOR

Physicians will be reminded of the current recommendations for emergency intubation: Rapid sequence intubation (RSI) using succinylcholine and use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.

Other: Data patientOther: Physical examinationProcedure: Rapid sequence intubation (RSI) : Recommendations for emergency intubation

Interventions

Medical History and characteristic of patient

Control GroupTreatment group

Arterial pressure, arterial oxygen saturation, heart rate

Control GroupTreatment group

Rapid sequence intubation (RSI) will be performed with use of rocuronium as paralytic agent (1.2 mg/ kg). Bag-mask ventilation between induction and laryngoscopy will be performed. The GEB will be systematically used at the first attempt to facilitate intubation.

Treatment group

Rapid sequence intubation (RSI) using succinylcholine as a paralytic agent (1 mg/kg), no systematic bag-mask ventilation between induction and laryngoscopy, use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient adult (≥ 18 years) presenting with vital distress requiring emergency tracheal intubation as assessed by the emergency physician in the out-of-hospital setting.
  • Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included.

You may not qualify if:

  • Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist).
  • Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis).
  • Patient that are not members of a medical aid scheme (beneficiary or main member).
  • Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

CHU d'Angers

Angers, 49933, France

RECRUITING

CH Carnelle Portes de l'Oise

Beaumont-sur-Oise, 95260, France

RECRUITING

AP-HP - Hôpital Avicenne

Bobigny, 93000, France

RECRUITING

CHU de Bordeaux - Hôpital Pellegrin

Bordeaux, 33000, France

RECRUITING

CH de Pontoise René Dubos

Cergy-Pontoise, 95303, France

RECRUITING

AP-HP - Hôpital Henri Mondor

Créteil, 94000, France

RECRUITING

CHU de Dijon

Dijon, 21000, France

NOT YET RECRUITING

GH Eaubonne Montmorency Hôpital Simone VEIL

Eaubonne, 95600, France

RECRUITING

AP-HP - Hôpital Raymond Poincaré

Garches, 92380, France

RECRUITING

CHU de Grenoble - Hôpital Nord La Tronche

La Tronche, 38700, France

RECRUITING

CH de Versailles - Site André Mignot

Le Chesnay, 78157, France

NOT YET RECRUITING

HCL - Hôpital Edouard Herriot

Lyon, 69003, France

RECRUITING

GH Sud Ile de France

Melun, 77000, France

RECRUITING

CHU de Montpellier Site Lapeyronie

Montpellier, 34000, France

RECRUITING

CHU de Nantes - Hôpital Hôtel Dieu

Nantes, 44093, France

RECRUITING

AP-HP - Hôpital Lariboisière

Paris, 75013, France

RECRUITING

AP-HP - Hôpital Pitié-Salpétrière

Paris, 75013, France

RECRUITING

AP-HP - Hôpital Necker

Paris, 75730, France

RECRUITING

CHU Poitiers - Hôpital la Milétrie

Poitiers, 86021, France

RECRUITING

CHU de la Réunion - site Sud

Saint-Pierre, 97448, France

RECRUITING

GH Sélestat Obernai

Sélestat, 67 600, France

NOT YET RECRUITING

CHU Toulouse - Hôpital Purpan

Toulouse, 31059, France

RECRUITING

MeSH Terms

Conditions

Emergencies

Interventions

Restraint, PhysicalRapid Sequence Induction and IntubationRocuronium

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative TechniquesIntubation, IntratrachealAirway ManagementIntubationAndrostanolsAndrostanesSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Officials

  • Xavier COMBES, Pr

    Université Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2022

First Posted

September 14, 2022

Study Start

January 14, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

September 24, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations